Trade Aeterna Zentaris - AEZS CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.0344 | ||||||||
|
Long position overnight fee
Long position overnight fee
Go to platform | -0.026179% | ||||||||
|
Short position overnight fee
Short position overnight fee
Go to platform | 0.003957% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 0.01 | ||||||||
| Currency | USD | ||||||||
| Margin | 5% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 1.9428 |
| Open | 1.9428 |
| 1-Year Change | -38.91% |
| Day's Range | 1.9428 - 1.9428 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 26, 2024 | 1.9428 | 0.0000 | 0.00% | 1.9428 | 1.9428 | 1.9328 |
| Apr 25, 2024 | 1.9428 | -0.0100 | -0.51% | 1.9528 | 1.9528 | 1.9328 |
| Apr 24, 2024 | 1.9528 | 0.0100 | 0.51% | 1.9428 | 1.9528 | 1.9428 |
| Apr 23, 2024 | 1.9528 | 0.0100 | 0.51% | 1.9428 | 1.9528 | 1.9428 |
| Apr 22, 2024 | 1.9428 | 0.0000 | 0.00% | 1.9428 | 1.9528 | 1.9128 |
| Apr 19, 2024 | 1.9428 | 0.0000 | 0.00% | 1.9428 | 1.9428 | 1.9128 |
| Apr 18, 2024 | 1.9428 | 0.0000 | 0.00% | 1.9428 | 1.9428 | 1.9328 |
| Apr 17, 2024 | 1.9428 | 0.0000 | 0.00% | 1.9428 | 1.9628 | 1.9328 |
| Apr 16, 2024 | 1.9428 | 0.0000 | 0.00% | 1.9428 | 1.9428 | 1.9328 |
| Apr 15, 2024 | 1.9428 | -0.0200 | -1.02% | 1.9628 | 1.9728 | 1.9428 |
| Apr 12, 2024 | 1.9628 | -0.0700 | -3.44% | 2.0328 | 2.0328 | 1.9628 |
| Apr 11, 2024 | 2.0328 | 0.0000 | 0.00% | 2.0328 | 2.0428 | 2.0328 |
| Apr 10, 2024 | 2.0328 | -0.0300 | -1.45% | 2.0628 | 2.0628 | 1.9628 |
| Apr 9, 2024 | 2.0628 | 0.0200 | 0.98% | 2.0428 | 2.0628 | 2.0428 |
| Apr 8, 2024 | 2.0428 | 0.1000 | 5.15% | 1.9428 | 2.0428 | 1.9428 |
| Apr 5, 2024 | 1.9728 | -0.0900 | -4.36% | 2.0628 | 2.0628 | 1.9428 |
| Apr 4, 2024 | 2.0628 | 0.0100 | 0.49% | 2.0528 | 2.1028 | 2.0528 |
| Apr 3, 2024 | 2.0528 | 0.0300 | 1.48% | 2.0228 | 2.1128 | 2.0228 |
| Apr 2, 2024 | 2.0428 | 0.0000 | 0.00% | 2.0428 | 2.1228 | 2.0428 |
| Apr 1, 2024 | 2.0928 | 0.0000 | 0.00% | 2.0928 | 2.1728 | 2.0728 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Aeterna Zentaris Company profile
Aeterna Zentaris Inc. (AEZS) is a biopharmaceutical company headquartered in Summerville, South Carolina.
Founded in 1990, the company specialises in diagnostics, therapeutics and Salmonella-based vaccine platforms. Its diagnostic drug, Macimorelin, for adult growth hormone deficiency (AGHD) is currently in the commercial phase. Macimorelin designed for childhood-onset growth hormone deficiency (CGHD) is in Phase 3 clinical trials.
The portfolio of therapeutic drugs includes AIM Biologicals for neuromyelitis optica spectrum disorder and Parkinson’s disease, Macimorelin for amyotrophic lateral sclerosis (ALS) and AEZS-150 for chronic hypoparathyroidism, all in the pre-clinical phase.
The vaccine programme is engaged in the development of vaccines for Covid-19 and Chlamydia trachomatis, both are in the pre-clinical trial.
Aeterna Zentaris leverages its network of large pharma and university partners and collaborators to develop and commercialise drugs faster. A licence agreement with the University of Wuerzburg is enabling the pharmaceutical company to develop the Covid-19 vaccine, treatment for neuromyelitis optica spectrum disorder and Parkinson's disease (preclinical phase); and 3D human intestinal tissue models to study infection.
Aeterna Zentaris has a development and commercialisation agreement for macimorelin with Novo Nordisk (NVO) and NK MEDITECH Ltd. It has an exclusive licence agreement with the University of Queensland, Australia for the investigation of macimorelin as a potential treatment for ALS.
The company went public in 2000, listing on the NASDAQ. Aeterna Zentaris stock trades under the ticker symbol AEZS.
You can follow the Aeterna Zentaris share value and price movement live through AEZS stock price chart at Capital.com.
| Industry: | Biotechnology & Medical Research (NEC) |
315 Sigma Drive
SUMMERVILLE
NEW BRUNSWICK 29486
CA
News
We’re partnering with Newsquawk
Filter out the noise and focus on the news that matters.
08:32, 23 April 2024
US Earnings Season: Tesla, Alphabet, Meta Platforms and Microsoft
The first lot of Wall Street’s mega-cap tech companies report in the coming week. We preview what to expect from Tesla, Alphabet, Meta, and Microsoft’s quarterly results.
15:56, 22 April 2024
Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported
Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.
07:56, 17 April 2024
US Earnings Season : JP Morgan, Citigroup, Wells Fargo
The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.
16:03, 11 April 2024
Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues
The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
09:22, 11 April 2024
US CPI Preview: US inflation expected to grind lower amid fears about sticky prices
US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).
15:11, 9 April 2024
How escalating geopolitical tensions are impacting oil markets
The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.
13:34, 4 April 2024People also watch
Still looking for a broker you can trust?
Join the 610,000+ traders worldwide that chose to trade with Capital.com